These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Granular parakeratosis: response to calcipotriene and brief review of current therapeutic options. Samrao A; Reis M; Niedt G; Rudikoff D Skinmed; 2010; 8(6):357-9. PubMed ID: 21413654 [TBL] [Abstract][Full Text] [Related]
13. Two episodes of axillary granular parakeratosis triggered by different causes: case report. Urbina F; Sudy E; Misad C Acta Dermatovenerol Croat; 2012; 20(2):105-7. PubMed ID: 22726284 [TBL] [Abstract][Full Text] [Related]
14. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543 [TBL] [Abstract][Full Text] [Related]
17. Isotretinoin as a treatment for axillary granular parakeratosis. Compton AK; Jackson JM Cutis; 2007 Jul; 80(1):55-6. PubMed ID: 17725066 [TBL] [Abstract][Full Text] [Related]
18. Granular parakeratosis: pathologic and clinical correlation of 18 cases of granular parakeratosis. Scheinfeld NS; Mones J J Am Acad Dermatol; 2005 May; 52(5):863-7. PubMed ID: 15858479 [TBL] [Abstract][Full Text] [Related]
19. Intertriginous granular parakeratosis responsive to potent topical corticosteroids. Chamberlain AJ; Tam MM Clin Exp Dermatol; 2003 Jan; 28(1):50-2. PubMed ID: 12558631 [TBL] [Abstract][Full Text] [Related]